At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SPRY ARS PHARMACEUTICALS INC
Not Yet Opened 06-25 16:00:00 EDT
7.65
-0.59
-7.16%
盘后8.03
+0.38+4.97%
19:43 EDT
High8.24
Low7.55
Vol815.35K
Open8.24
D1 Closing8.24
Amplitude8.37%
Mkt Cap741.25M
Tradable Cap328.40M
Total Shares96.90M
T/O6.41M
T/O Rate1.90%
Tradable Shares42.93M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
ARS Pharmaceuticals On Track With Neffy Despite Regulatory Hurdles
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for patients and parents affected by severe allergic reactions. It is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for patients and their caregivers with type I allergic reactions, including anaphylaxis. The company was founded in 2015 and is based in San Diego, California.